open access

Vol 49, No 1 (2018)
Case Report
Submitted: 2016-12-28
Published online: 2018-03-30
Get Citation

Massive bone marrow necrosis associated with Waldenström’s macroglobulinemia

Rie Tabata1, Chiharu Tabata2, Ryoji Yasumizu3
DOI: 10.2478/ahp-2018-0005
·
Acta Haematol Pol 2018;49(1):28-32.
Affiliations
  1. Department of Hematology and Rheumatology, Saiseikai-Noe Hospital, Osaka, Japan
  2. Hyogo College of Medicine Cancer Center, Hyogo, Japan
  3. Department of Pathology, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan

open access

Vol 49, No 1 (2018)
Case Report
Submitted: 2016-12-28
Published online: 2018-03-30

Abstract

Here, we report a rare case of massive bone marrow necrosis, which – from the clinical findings and images – mimics disseminated bone metastasis. The patient was suffering from severe bone pain with elevated levels of serum alkaline phosphatase (ALP) and lactate dehydrogenase (LDH); moreover, strong incorporation of 18F-fluorodeoxyglucose in multiple bones was observed by positron emission tomography/computed tomography.

The underlying disease was Waldenström’s macroglobulinemia, which was thought to transform to cluster of differentiation 5 (CD5)-positive diffuse large B-cell lymphoma (DLBCL). The case showed a highly aggressive course, although the original Waldenström’s macroglobulinemia was in the stable state.

Clinicians should be aware of the co-occurrence of non-immunoglobulin-producing immature lymphoma, even with good course of Waldenström’s macroglobulinemia, and should pay attention to accompanying massive bone marrow necrosis, which mimics multiple cancer metastases to the bone. To the best of our knowledge, the present case is the first report of CD5-positive DLBCL transformed from CD5-negative Waldenström’s macroglobulinemia.

Abstract

Here, we report a rare case of massive bone marrow necrosis, which – from the clinical findings and images – mimics disseminated bone metastasis. The patient was suffering from severe bone pain with elevated levels of serum alkaline phosphatase (ALP) and lactate dehydrogenase (LDH); moreover, strong incorporation of 18F-fluorodeoxyglucose in multiple bones was observed by positron emission tomography/computed tomography.

The underlying disease was Waldenström’s macroglobulinemia, which was thought to transform to cluster of differentiation 5 (CD5)-positive diffuse large B-cell lymphoma (DLBCL). The case showed a highly aggressive course, although the original Waldenström’s macroglobulinemia was in the stable state.

Clinicians should be aware of the co-occurrence of non-immunoglobulin-producing immature lymphoma, even with good course of Waldenström’s macroglobulinemia, and should pay attention to accompanying massive bone marrow necrosis, which mimics multiple cancer metastases to the bone. To the best of our knowledge, the present case is the first report of CD5-positive DLBCL transformed from CD5-negative Waldenström’s macroglobulinemia.

Get Citation

Keywords

bone marrow necrosis; bone tumor; CD5; diffuse large B-cell lymphoma; Waldenström’s macroglobulinemia

About this article
Title

Massive bone marrow necrosis associated with Waldenström’s macroglobulinemia

Journal

Acta Haematologica Polonica

Issue

Vol 49, No 1 (2018)

Pages

28-32

Published online

2018-03-30

Page views

121

Article views/downloads

174

DOI

10.2478/ahp-2018-0005

Bibliographic record

Acta Haematol Pol 2018;49(1):28-32.

Keywords

bone marrow necrosis
bone tumor
CD5
diffuse large B-cell lymphoma
Waldenström’s macroglobulinemia

Authors

Rie Tabata
Chiharu Tabata
Ryoji Yasumizu

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl